Related Experiment Video
Updated: Dec 23, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
[Study of triptolide-induced apoptosis in MUTZ-1 cells and its allied mechanism]
1Department of Hematology, The First Affiliated Hospital, College of Medicine of Zhejiang University, Zhejiang Institution of Hematology, Hangzhou 310003, China.
Abstract:
To investigate the apoptotic effect of triptolide on MDS cell line MUTZ-1 cells and its mechanism, MUTZ-1 cells were incubated with indicated concentrations of triptolide. The growth of MUTZ-1 cells was observed by MTT assay and apoptosis was detected by DNA fragmentation analysis and flow cytometry using Annexin V-FITC/PI staining. The gene and protein expressions were determined by reverse transcription polymerase chain reaction (RT-PCR) and Western blot, respectively. The results showed that MUTZ-1 cell viability in presence of triptolide decreased markedly in a dose- and time-dependent manner. The growth-inhibitory IC50 value for triptolide treatment was 55.06 ng/ml. A DNA ladder pattern of internucleosomal fragmentation was observed. The translocation of phosphatidylserine at the outer surface of the cell plasma membrane could be induced by triptolide and its level increased following the augmentation of the drug concentration. Treatment of MUTZ-1 cells with triptolide for 12 hours resulted in the activation of caspase-3, cleavage of PARP and decrease of c-IAP2 mRNA. The expressions of pro-caspase 3 and c-IAP2 were inversely correlated with the incidence of apoptosis. (r = -0.907, P = 0.000; r = -0.919, P = 0.000 respectively). In conclusion, Triptolide inhibits MUTZ-1 cell growth by inducing apoptosis. The apoptotic effect of triptolide in MUTZ-1 cells is mediated by the caspase-3 activation and PARP cleavage. Moreover, the activation of caspase-3 may be associated with the down-regulation of c-IAP2.
Insights
Triptolide effectively inhibits Myelodysplastic Syndrome (MDS) cell growth by inducing apoptosis in MUTZ-1 cells. This process involves caspase-3 activation and PARP cleavage, potentially linked to reduced c-IAP2 expression.
Area of Science:
- Molecular Biology
- Cell Biology
- Pharmacology
Background:
- Myelodysplastic Syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
- Identifying novel therapeutic agents targeting MDS cell proliferation is crucial.
Purpose of the Study:
- To investigate the apoptotic effects of triptolide on the MDS cell line MUTZ-1.
- To elucidate the underlying molecular mechanisms of triptolide-induced apoptosis.
Main Methods:
- Cell viability assessed using MTT assay.
- Apoptosis detected via DNA fragmentation analysis and Annexin V-FITC/PI staining (flow cytometry).
- Gene and protein expression analyzed by RT-PCR and Western blot, respectively.
Main Results:
- Triptolide significantly inhibited MUTZ-1 cell viability in a dose- and time-dependent manner (IC50 = 55.06 ng/ml).
- DNA fragmentation and phosphatidylserine translocation indicated apoptosis induction.
- Triptolide treatment activated caspase-3, cleaved PARP, and decreased c-IAP2 mRNA expression.
Conclusions:
- Triptolide effectively inhibits MUTZ-1 cell growth through apoptosis induction.
- Caspase-3 activation and PARP cleavage are key mediators of triptolide's apoptotic effect.
- Down-regulation of c-IAP2 may be associated with caspase-3 activation in triptolide-treated cells.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Drugs that Stabilize Microtubules